These findings were supported by the present study that there were strongly positive correlations between the expression of AIB1 and ErbB receptors in gastric cancers, and knocking down AIB1 expression in gastric cancer cells significantly reduced the expression of ErbB receptors. The gene discussed is NCOA3; the disease is gastric cancer.